Stimulation of breast cancer invasion and metastasis by synuclein γ1

Cancer Research

Volumn 59, Issue 3, 1999, Pages 742-747

  Jia, Tongli ^a   Liu, Yiliang E ^a   Liu, Jingwen ^b   Shi, Y Eric ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; SYNUCLEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; DNA SEQUENCE; FEMALE; GROWTH REGULATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL MOVEMENT; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; STIMULATION, CHEMICAL; SYNUCLEINS; TRANSFECTION;

EID: 0033083049     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Porter-Jordan, K., and Lippman, M. E. Overview of the biological markers of breast cancer. Hematol. Oncol. Clin. N. Am., 8: 73-100, 1994.
2. Ji, H., Liu, Y. E., Jia, T., Wang, M., Lin, J., Xiao, G., Joseph, B. K., Rosen, C., and Shi, Y. E. Identification of a breast cancer-specific gene, BCSG1, by direct differential complementary DNA sequencing. Cancer Res., 57: 759-764, 1997.
3. Shi, Y. E., Ni, J., Xiao, G., Liu, Y. E., Fuchs, A., Yu, G., Su, J., Cosgrove, J. M., Xing, L., Zhang, M., Li, J., Aggarwal, B. B., Meager, A., and Gentz, R. Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res., 57: 3084-3091, 1997.
4. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., and Saitoh, T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90: 11282-11286, 1993.
5. Xia, Y., Rohan-de-Silva, H. A., Rosi, B. L., Yamaoka, L. H., Rimmler, J. B., Pericak-Vance, M. A. Ross, A. D., Chen, X., Masliah, E., DeTeresa, R., Iwai, A., Sundsmo, M., Thomas, R. G., Hofstetter, C. R., Gregory, E., Hansen, L. A., Katzman, R., Thai, L. J., and Saitoh, T. Genetic studies in Alzheimer's disease with an NACP/α-synuclein polymorphism. Ann. Neurol., 40: 207-215, 1996.
6. Jakes, R., Spillantini, M. G., and Goedert, M. Identification of two distinct synucleins from human brain. FEBS Lett., 345: 27-34, 1994.
7. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. α-Synuclein in Lewy bodies. Nature (Lond.), 388: 839-840, 1997.
8. Masters, C. L., Simms, G., Wenman, N. A., Multhup, G., McDonald, B. L., and Beyreuther, K. Amyloid plaque core in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA, 82: 4245-4249, 1985.
9. Clayton, D. F., and George, J. M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci., 21: 249-254, 1998.
10. Takeda, A., Mallory, M., Sundsmo, M., Honer W., Hansen, L., and Masliah, E. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. J. Pathol., 152: 367-372, 1998.
11. Wang, M., Liu, Y. E., John, G., Sheng, S., Fuchs, F., Rosen, E. M., and Shi, Y. E. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene, 14: 2767-2774, 1997.
12. Liu, Y. E., Wang, M., Greene, J., Su, J., Ullrich, S., Sheng, S., Alexander, P., Sang, Q. A., and Shi, Y. E. Preparation and characterization of recombinant TIMP-4 protein. J. Biol. Chem., 272: 20479-20483, 1997.
13. Shi, Y. E., Torri, J., Yieh, L., Wellstein, A., Lippman, M. E., and Dickson, R. B. Isolation and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res., 53: 1409-1415, 1993.
14. Deb, S., and Gottschall, P. E. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with β-amyloid peptides. J. Neurochem., 66: 1641-1647, 1996.
15. Pyke, C., Ralfkiaer, E., Tryggvason, K., and Dano, K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142: 359-365, 1993.
16. Naylor, M. S., Stamp, G. W., Davies, B. D., and Balkwill, F. R. Expression and activity of MMPS and their regulators in ovarian cancer. Int. J. Cancer, 58: 50-56, 1994.
17. Polette, M., Clavel, C., Birembaut, P., and De-Clerck, Y. A. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol. Res. Pract., 189: 1052-1057, 1993.
18. Urbanski, S. J., Edwards, D. R., Maitland, A., Leco, K. J., Watson, A., and Kossakowska, A. E. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br. J. Cancer, 66: 1188-1194, 1992.
19. Tryggvason, K., Hoyhtya, M., and Pyke, C. Type IV collagenases in invasive tumors. Breast Cancer Res. Treat., 24: 209-218, 1993.
20. Polette, M., Clavel, C., Cockett, M., Girod-de-Bentzmann, S., Murphy, G., and Birembaut, P. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis, 13: 31-37, 1993.
21. Basset, P., Wolf, C., Rouyer, N., Bellocq, J. P., Rio, M. C., and Chambon, P. Stromelysin-3 in stromal tissue as a control factor in breast career behavior. Cancer (Phila.), 74: 1045-1049, 1994.
22. Heppner, K. J., Matrisian, L. M., Jensen, R. A., and Rodgers, W. H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol., 149: 273-282, 1996.
23. Stettler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
24. Maccioni, R. B., and Cambiazo, V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol. Rev., 75: 835-865, 1995.
25. Zading, J. M., Shoyab, M., Marquardt, H., Hanson, M., Lioubin, M. N., and Tdaro, G. J. Oncostatin M: a growth regulator produced by differentiated lymphoma cells. Proc. Natl. Acad. Sci. USA, 83: 9739-9743, 1986.
26. Liu, J., Spence, M. J., Wallace, P. M., Forcier, K., Hellstrom, I., and Vestal, R. E. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Cell Growth Differ., 8: 667-676, 1997.
27. Spence, M. J., Vestal, R. E., and Liu, J. Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells. Cancer Res., 57: 2223-2228, 1997.
28. Douglas, A. M., Grant, S. L., Goss, G. A., Clouston, D. R., Sutherland, R. L., and Begley, C. G. Oncostatin M induces the differentiation of breast cancer cells. Int. J. Cancer, 75: 64-73, 1998.